Syndax Pharmaceuticals
Biotechnology
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company focused on oncology, with two commercially approved medicines: Revuforj (revumenib) and Niktimvo (axatilimab).
- Revuforj (revumenib)
- Niktimvo (axatilimab)
Open roles at Syndax Pharmaceuticals
2 matching roles
Unspecified
New York City, New York, United States +1 more
Director
$270k to $290k USD
- Management Occupations
- CMC
Posted 4 days ago
Source: Greenhouse
Unspecified
New York City, New York, United States +1 more
Director
$270k to $290k USD
- Management Occupations
- CMC
Posted 4 days ago
Source: Greenhouse
Showing 2 of 2 roles